Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus

被引:0
|
作者
Li, Shihong [1 ]
Li, Zhizhong [1 ]
Hou, Xuejian [1 ]
Sun, Junping [1 ]
Kang, Lihui [1 ]
Cheng, Yutong [1 ]
Tao, Ying [1 ]
Li, Zhao [1 ]
Chen, Xuanzu [1 ]
Zhang, Donghua [1 ]
Yan, Xianliang [1 ]
Wang, Su [1 ]
Gao, Yulong [1 ]
Wang, Qian [1 ]
Lin, Yun [1 ]
Yin, Chengqian [1 ]
Zhang, Jingmei [1 ]
Gao, Yun [1 ]
Huang, Ji [1 ]
Wu, Xiangyu [1 ]
Li, Nan [1 ]
Su, Wang [1 ]
Liu, Honghong [1 ]
Sun, Tao [1 ]
机构
[1] Capital Med Univ, Beijing Zhen Hosp, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
关键词
Diabetes mellitus; safety and cost; acute coronary syndrome; percutaneous coronary intervention; early discharge; hospitalization; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; SAME-DAY DISCHARGE; LENGTH-OF-STAY; HEART-DISEASE; CARDIOVASCULAR-ANGIOGRAPHY; ARTERY-DISEASE; IMPACT; REVASCULARIZATION; METAANALYSIS;
D O I
10.1177/0300060519842777
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective To evaluate the safety and cost of early discharge compared with ordinary discharge in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods We performed a retrospective analysis of prospectively collected data from 474 patients with DM who were discharged from hospital following PCI at a regional center between 2012 and 2015. Results A total of 192 patients (40.5%) were included in the early discharge group and 282 patients (59.5%) were included in the ordinary group. Mortality and morbidity after PCI were recorded. Kaplan-Meier analysis showed similar prognosis between the two groups at 30 days and at 1 year after discharge. However, hospitalization expenses for the regular discharge group were significantly higher than those of the early discharge group (RMB65,750 vs. RMB50,983). Conclusion Our findings demonstrate that early discharge of patients with DM following PCI for acute coronary syndrome is safe compared with ordinary discharge, and may reduce hospitalization costs.
引用
收藏
页码:3905 / 3917
页数:13
相关论文
共 50 条
  • [31] Patients' Perspectives With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Qin, Hong
    Mayer, Hanna
    Ozturk, Begum
    Eslam, Roza Badr
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (05): : 588 - 593
  • [32] Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention
    Faggioni, Michela
    Baber, Usman
    Chandrasekhar, Jaya
    Sartori, Samantha
    Claessen, Bimmer E.
    Rao, Sunil V.
    Vogel, Birgit
    Effron, Mark B.
    Poddar, Kanhaiya
    Farhan, Serdar
    Kini, Annapoorna
    Weintraub, William
    Toma, Catalin
    Sorrentino, Sabato
    Weiss, Sandra
    Snyder, Clayton
    Muhlestein, Joseph B.
    Kapadia, Samir
    Keller, Stuart
    Strauss, Craig
    Aquino, Melissa
    Baker, Brian
    Defranco, Anthony
    Pocock, Stuart
    Henry, Timothy
    Mehran, Roxana
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 275 : 31 - 35
  • [33] Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Ma, Xiaoteng
    Sun, Yan
    Cheng, Yujing
    Shen, Hua
    Gao, Fei
    Qi, Jing
    Yang, Lixia
    Wang, Zhijian
    Shi, Dongmei
    Liu, Yuyang
    Liu, Xiaoli
    Zhou, Yujie
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [34] Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Xiaoteng Ma
    Yan Sun
    Yujing Cheng
    Hua Shen
    Fei Gao
    Jing Qi
    Lixia Yang
    Zhijian Wang
    Dongmei Shi
    Yuyang Liu
    Xiaoli Liu
    Yujie Zhou
    Lipids in Health and Disease, 19
  • [35] Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
    Piccolo, Raffaele
    Franzone, Anna
    Koskinas, Konstantinos C.
    Raber, Lorenz
    Pilgrim, Thomas
    Valgimigli, Marco
    Stortecky, Stefan
    Rat-Wirtzler, Julie
    Silber, Sigmund
    Serruys, Patrick W.
    Juni, Peter
    Heg, Dik
    Windecker, Stephan
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (03): : 345 - 352
  • [36] Safety and Outcomes of Percutaneous Coronary Intervention in Patients Presenting With Acute Coronary Syndrome With Prior Liver Transplantation
    Abumoawad, Abdelrhman
    Ahmed, Mohamed
    Baweja, Paramdeep
    Gupta, Kamal
    CIRCULATION, 2022, 146
  • [37] Feasibility and safety of non-contrast percutaneous coronary intervention in patients with complicated acute coronary syndrome
    Higuchi, S.
    Kabeya, Y.
    Nishina, Y.
    Miura, Y.
    Yoshino, H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1751 - 1751
  • [38] Percutaneous Coronary Intervention, Diabetes Mellitus, and Death
    Dauerman, Harold L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) : 1076 - 1079
  • [39] Efficacy and Safety of Prasugrel Compared With Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Wang, Amy
    Lella, Leela K.
    Brener, Sorin J.
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (06) : E1637 - E1643